Kerol Bartolović

Inhibitory effect of imatinib on normal progenitor cells in vitro

Kerol Bartolović, Stefan Balabanov, Ulrike Hartmann et al. · Blood · 2003 · 96 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +7

CDCP1 Identifies a Broad Spectrum of Normal and Malignant Stem/Progenitor Cell Subsets of Hematopoietic and Nonhematopoietic Origin

Hans‐Jörg Bühring, Selim Kuçi, Tim Conze et al. · Stem Cells · 2004 · 78 citations

Medicine, Cell Biology, Hematology +17

Defining the identity and the niches of epithelial stem cells with highly pleiotropic multilineage potency in the human thymus

Roberta Ragazzini, Stefan Boeing, Luca Zanieri et al. · Developmental Cell · 2023 · 64 citations · Full text

Life Sciences, Cell Biology, Immunology +17

The differentiation and engraftment potential of mouse hematopoietic stem cells is maintained after bio-electrospray

Kerol Bartolović, Napachanok Mongkoldhumrongkul, Simon N. Waddington et al. · The Analyst · 2009 · 37 citations

Life Sciences, Bioengineering, Cell Biology +15

Normalization of Previously Shortened Telomere Length under Treatment with Imatinib Argues against a Preexisting Telomere Length Deficit in Normal Hematopoietic Stem Cells from Patients with Chronic Myeloid Leukemia

Tim H. Brümmendorf, Inci Ersöz, Ulrike Hartmann et al. · Annals of the New York Academy of Sciences · 2003 · 28 citations

Life Sciences, Hematology, Molecular Biology +15